Mission Creek Capital Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $400K | Buy |
5,798
+43
| +0.7% | +$2.97K | 0.09% | 147 |
|
2025
Q1 | $400K | Buy |
5,755
+105
| +2% | +$7.29K | 0.1% | 151 |
|
2024
Q4 | $486K | Sell |
5,650
-12,712
| -69% | -$1.09M | 0.11% | 157 |
|
2024
Q3 | $2.19M | Buy |
18,362
+395
| +2% | +$47K | 0.51% | 57 |
|
2024
Q2 | $2.56M | Buy |
17,967
+6,525
| +57% | +$931K | 0.65% | 42 |
|
2024
Q1 | $1.47M | Buy |
11,442
+3,620
| +46% | +$465K | 0.38% | 74 |
|
2023
Q4 | $809K | Sell |
7,822
-100
| -1% | -$10.3K | 0.21% | 122 |
|
2023
Q3 | $720K | Sell |
7,922
-660
| -8% | -$60K | 0.24% | 123 |
|
2023
Q2 | $694K | Sell |
8,582
-1,978
| -19% | -$160K | 0.22% | 130 |
|
2023
Q1 | $840K | Sell |
10,560
-110
| -1% | -$8.75K | 0.29% | 111 |
|
2022
Q4 | $722K | Sell |
10,670
-950
| -8% | -$64.3K | 0.26% | 115 |
|
2022
Q3 | $579K | Sell |
11,620
-200
| -2% | -$9.97K | 0.22% | 129 |
|
2022
Q2 | $659K | Hold |
11,820
| – | – | 0.22% | 127 |
|
2022
Q1 | $656K | Hold |
11,820
| – | – | 0.18% | 146 |
|
2021
Q4 | $662K | Sell |
11,820
-400
| -3% | -$22.4K | 0.13% | 155 |
|
2021
Q3 | $587K | Sell |
12,220
-480
| -4% | -$23.1K | 0.11% | 160 |
|
2021
Q2 | $532K | Sell |
12,700
-200
| -2% | -$8.38K | 0.09% | 159 |
|
2021
Q1 | $435K | Hold |
12,900
| – | – | 0.06% | 168 |
|
2020
Q4 | $451K | Hold |
12,900
| – | – | 0.14% | 153 |
|
2020
Q3 | $448K | Sell |
12,900
-144
| -1% | -$5K | 0.18% | 139 |
|
2020
Q2 | $427K | Sell |
13,044
-950
| -7% | -$31.1K | 0.22% | 106 |
|
2020
Q1 | $421K | Sell |
13,994
-200
| -1% | -$6.02K | 0.23% | 98 |
|
2019
Q4 | $411K | Buy |
+14,194
| New | +$411K | 0.19% | 126 |
|